CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2012		Jun. 30, 2011
Cash flows from operating activities:
Net loss before non-controlling interest	$ (2,518)		$ (4,848)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	15		42
Amortization of intangible assets	17		0
Amortization of convertible note discount	43		0
Amortization of deferred financing costs	33		0
Revaluation of warrant liability	610		0
Stock-based compensation expense	229		191
Loss on disposal of property and equipment	2		0
Assignment of Medicsight's stock	0		(4)
Gain on sale of loan receivable - related party	0		(81)
(Increase)/decrease in assets:
Accounts receivable	72		(176)
Other receivables - related party	0		47
Proceeds from release of security deposits	140		0
Prepaid expenses and other current assets	241		(337)
Inventory	36		0
Increase/(decrease) in liabilities:
Accounts payable	71		197
Accrued expenses	(5)		(154)
Other payables	(23)		0
Net cash used in operating activities	(1,037)		(5,123)
Cash flows from investing activities:
Purchase of property and equipment	(12)		0
Purchase of intangible asset	(200)		0
Repayment of Dunamis loan	0		1,100
Receipts from sale of Moneygate	0		401
Receipts of deferred consideration for sale of assets	0		370
Receipts from sale of Medicsight's stock	0		110
Net cash (used in) / provided by investing activities	(212)		1,981
Cash flows from financing activities:
Cash paid in lieu of fractional shares in reverse/forward split	(5)		0
Proceeds from issuance of convertible note	3,500		0
Payments for convertible note issuance costs	(372)		0
Net cash provided by financing activities	3,123		0
Effects of exchange rates on cash and cash equivalents	80		412
Net change in cash and cash equivalents	1,954		(2,730)
Cash and cash equivalents, beginning of period	3,704	[1]	8,434
Cash and cash equivalents, end of period	5,658		5,704
Supplemental non-cash disclosures (investing and financing activities):
Stock issued for services in connection with issuance of convertible note	315		0
Warrants issued in connection with acquisition of intangible assets	851		0
Warrants issued in connection with issuance of convertible note	500		0
Beneficial conversion on convertible note	500		0
Intangible asset contributed by non-controlling interest	$ 862		$ 0

[1] Derived from audited financial information